Shift from Darbepoetin-α to Continuous Erythropoietin Receptor Activator Decreases Serum Aluminium Concentration in Patients on Hemodialysis

Conclusion We found the shift from DPO to CERA results in lower Al levels, a reduced inflammatory response, and an increase in RBC number and PTH level in uremic patients on hemodialysis.
Source: Environmental Toxicology and Pharmacology - Category: Environmental Health Source Type: research